Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00135070
Status:
TERMINATED
Last Update Posted:
2007-05-01
First Post:
2005-08-23
Brief Title:
Hospital In-Patient Insulin Study
Sponsor:
The Royal Bournemouth Hospital
Organization:
The Royal Bournemouth Hospital
Study Overview
Official Title:
A Randomised Study Comparing Continuous Intravenous Insulin Infusion With Subcutaneous Insulin Analogues in Hospitalised Patients With Type II Diabetes and Hyperglycaemia
Status:
TERMINATED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No documentation with MHRA to support clinical trial of a medicinal product
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hyperglycaemia has been shown to increase morbidity and mortality in patients with critical illness myocardial infarction and stroke This study aims to look at patients with hyperglycaemia and reduce their blood sugar levels using differing combinations of subcutaneous and intravenous insulin
Detailed Description:
This is a randomised trial involving patients with type II diabetes who are brought into the hospital with a problem other than a diabetic emergency Patients will be included who have a blood sugar than 17mmols They will be randomised to one of two groups and either given intravenous or subcutaneous insulin Outcome measures are length of stay glucose control and comparison of the two regimens Cost implications will also be analysed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None